Stability, safety, and pharmacokinetics of ganciclovir eye drops prepared from ganciclovir for intravenous infusion

[1]  S. Chee,et al.  Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study , 2018, PloS one.

[2]  N. Koizumi,et al.  The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis , 2016, British Journal of Ophthalmology.

[3]  J. Kiel,et al.  Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days , 2016, Cornea.

[4]  H. Isomura,et al.  Analysis of human cytomegalovirus replication in primary cultured human corneal endothelial cells , 2015, British Journal of Ophthalmology.

[5]  N. Koizumi,et al.  Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study , 2014, British Journal of Ophthalmology.

[6]  T. Higashide,et al.  Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis. , 2012, American journal of ophthalmology.

[7]  S. Chee,et al.  Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[8]  S. Chee,et al.  Immune ring formation associated with cytomegalovirus endotheliitis. , 2011, American journal of ophthalmology.

[9]  W. Chuang,et al.  Cytomegalovirus associated corneal endotheliitis after penetrating keratoplasty in a patient with Fuchs corneal endothelial dystrophy , 2010, British Journal of Ophthalmology.

[10]  Y. Tano,et al.  Prevalence and features of keratitis with quantitative polymerase chain reaction positive for cytomegalovirus. , 2010, Ophthalmology.

[11]  J. Mehta,et al.  Cytomegalovirus endotheliitis in Descemet's stripping endothelial keratoplasty. , 2009, Ophthalmology.

[12]  N. Koizumi,et al.  Cytomegalovirus as an etiologic factor in corneal endotheliitis. , 2008, Ophthalmology.

[13]  G. Wormser,et al.  Bacterial contamination of ophthalmic solutions used in an extended care facility , 2007, British Journal of Ophthalmology.

[14]  S. Chee,et al.  Corneal endotheliitis associated with evidence of cytomegalovirus infection. , 2007, Ophthalmology.

[15]  Y. Ohashi,et al.  DNA of Cytomegalovirus Detected by PCR in Aqueous of Patient With Corneal Endotheliitis After Penetrating Keratoplasty , 2007, Cornea.

[16]  E. Rocha,et al.  Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation , 2006, Bone Marrow Transplantation.

[17]  N. Koizumi,et al.  Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. , 2006, American journal of ophthalmology.

[18]  J. Wilson,et al.  Microbial contamination of preservative free eye drops in multiple application containers , 2006, British Journal of Ophthalmology.

[19]  Darlene Miller,et al.  In‐use study of potential bacterial contamination of ophthalmic moxifloxacin , 2005, Journal of cataract and refractive surgery.

[20]  T. Oshika,et al.  Corneal endotheliitis and idiopathic sudden sensorineural hearing loss. , 2002, American journal of ophthalmology.

[21]  M. Araie,et al.  Herpes simplex virus in the trabeculum of an eye with corneal endotheliitis. , 1999, American journal of ophthalmology.

[22]  R. Schumer,et al.  Microbial contamination of medications used to treat glaucoma. , 1995, British Journal of Ophthalmology.

[23]  R. Herriot,et al.  Owl's-Eye Cells , 1994 .

[24]  R. Herriot,et al.  Images in clinical medicine. Owl's-eye cells. , 1994, The New England journal of medicine.

[25]  K. Kenyon,et al.  Microbial contamination of in-use ocular medications. , 1992, Archives of ophthalmology.

[26]  S. Kinoshita,et al.  Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. , 1991, American journal of ophthalmology.

[27]  M. Ohji,et al.  Idiopathic corneal endotheliopathy. A report of two cases. , 1985, Archives of ophthalmology.

[28]  H. Kaufman,et al.  Progressive herpetic corneal endotheliitis. , 1985, American journal of ophthalmology.

[29]  E. Sutcliffe,et al.  Acute idiopathic corneal endotheliitis. , 1984, Transactions of the American Ophthalmological Society.

[30]  J. D. Karkas,et al.  9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Khodadoust,et al.  Presumed autoimmune corneal endotheliopathy. , 1982, American journal of ophthalmology.

[32]  E. De Clercq,et al.  Varicella-zoster virus in the human corneal endothelium: a case report. , 1980, Bulletin de la Societe belge d'ophtalmologie.